A good leader trying really hard to bring the company back up.: opiniones de empleados con el puesto de Biologist en Merck

4,0
7 dic 2008
Recomendar
Aprobación del CEO
Perspectiva de la empresa

Ventajas

Good compensation was my primary reason. I received a healthy weekly paycheck. However, my job was salaried and I did a lot of overtime, but there wasn't any compensation for that. One of the other reasons I chose to work at Merck was that their current research areas are in fields that I eventually want to get into, so its helpful to start out in a similar field. Also, because its a huge company, you can move around a lot within the different deparments: antiviral, RNA, drug metabolism, clincial trials etc. This also makes it a good place to work.

Desventajas

There are very few opportunities to advance within the different departments. You can be a master's degree employee and you might just stay at the same title for 7 to 15 years. They prefer to advance the Ph.D over the employees who've been working there for a long time. Also, people aren't that good at Merck. Some supervisors too ambitious to give credit to those under them. There's hardly and unity or sense of community within Merck. Also, you need to be careful of your money. Merck will really encourage their employees to invest in their stock. Stay away from that, unless you really like Merck.

Echa un vistazo a otras opiniones sobre Merck.

5,0
30 jun 2026
Recomendar
Aprobación del CEO
Perspectiva de la empresa

Ventajas

Excellent company to work with.

Desventajas

No cons encountered so far

4,0
30 jun 2026
Recomendar
Aprobación del CEO
Perspectiva de la empresa

Ventajas

Great benefits like medical/dentist/vision, pension, stock option, 401k match. Co workers are excellent, pretty good on site symposiums, lot of diversity clubs/activities. Innovation is extremely welcomed. Diversity in research portfolio. AI/ML is heavily invested to make databases more efficient.

Desventajas

Micro managing, especially within the biologics department, potentially others. Promotions are limited, and pay bump is poor. Company invests too much in buying companies rather than keeping talent - lay offs let go of great talented people. Merck is afraid of investing into exploratory biology and doesn’t take risk - they even admit they would rather see other companies clinical data or R&D data rather than taking a risk. Although it’s slow going in building new software, current databases are slow and needs much improvement. Extremely poor work/life balance.

Ver opiniones por: Útil|Valoración|Fecha|Todo